Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity

Journal of Proteome Research

Volumn 12, Issue 5, 2013, Pages 2282-2294

  Martinez Skinner, Andrea L ^a   Veerubhotla, Ram S ^a   Liu, Han ^a   Xiong, Huangui ^a   Yu, Fang ^b   McMillan, Joellyn M ^a   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

cell function; monocyte derived macrophages; nanoART; proteome; pulsed stable isotope labeling of amino acids in cell culture

Indexed keywords

ANTIRETROVIRUS AGENT; NANOCARRIER;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACCUMULATION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG METABOLISM; DRUG RELEASE; DRUG TRANSPORT; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; MACROPHAGE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MOLECULAR INTERACTION; MONONUCLEAR PHAGOCYTE; NANOTECHNOLOGY; PATIENT COMPLIANCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANTI-HIV AGENTS; BENZOXAZINES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; CYTOSKELETAL PROTEINS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; MACROPHAGES; MEMBRANE POTENTIALS; NANOPARTICLES; OLIGOPEPTIDES; PARTICLE SIZE; PHAGOCYTOSIS; POTASSIUM CHANNELS; PROTEOME; PYRIDINES; RITONAVIR;

EID: 84877149163     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400185w     Document Type: Article

References (58)

1. Chen, R. Y.; Westfall, A. O.; Raper, J. L.; Cloud, G. A.; Chatham, A. K.; Acosta, E. P.; Pham, S. V.; Tolson, J. M.; Heudebert, G. R.; Saag, M. S. Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice AIDS Res. Hum. Retroviruses 2002, 18 (13) 909-916
2. Chulamokha, L.; DeSimone, J. A.; Pomerantz, R. J. Antiretroviral therapy in the developing world J. Neurovirol. 2005, 11 (Suppl 1) 76-80
3. Fellay, J.; Boubaker, K.; Ledergerber, B.; Bernasconi, E.; Furrer, H.; Battegay, M.; Hirschel, B.; Vernazza, P.; Francioli, P.; Greub, G.; Flepp, M.; Telenti, A. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Lancet 2001, 358 (9290) 1322-1327
4. Hawkins, T. Appearance-related side effects of HIV-1 treatment AIDS Patient Care STDs 2006, 20 (1) 6-18
5. Shehu-Xhilaga, M.; Tachedjian, G.; Crowe, S. M.; Kedzierska, K. Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1 Curr. Med. Chem. 2005, 12 (15) 1705-1719
6. Bressani, R. F.; Nowacek, A. S.; Singh, S.; Balkundi, S.; Rabinow, B.; McMillan, J.; Gendelman, H. E.; Kanmogne, G. D. Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage Nanotoxicology 2011, 5 (4) 592-605
7. Dou, H.; Destache, C. J.; Morehead, J. R.; Mosley, R. L.; Boska, M. D.; Kingsley, J.; Gorantla, S.; Poluektova, L.; Nelson, J. A.; Chaubal, M.; Werling, J.; Kipp, J.; Rabinow, B. E.; Gendelman, H. E. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery Blood 2006, 108 (8) 2827-2835
8. Dou, H.; Morehead, J.; Destache, C. J.; Kingsley, J. D.; Shlyakhtenko, L.; Zhou, Y.; Chaubal, M.; Werling, J.; Kipp, J.; Rabinow, B. E.; Gendelman, H. E. Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages Virology 2007, 358 (1) 148-158
9. Nowacek, A. S.; McMillan, J.; Miller, R.; Anderson, A.; Rabinow, B.; Gendelman, H. E. Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics J. Neuroimmune Pharmacol. 2010, 5 (4) 592-601
10. Nowacek, A. S.; Miller, R. L.; McMillan, J.; Kanmogne, G.; Kanmogne, M.; Mosley, R. L.; Ma, Z.; Graham, S.; Chaubal, M.; Werling, J.; Rabinow, B.; Dou, H.; Gendelman, H. E. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery Nanomedicine (London) 2009, 4 (8) 903-917
11. Azzam, R.; Lal, L.; Goh, S. L.; Kedzierska, K.; Jaworowski, A.; Naim, E.; Cherry, C. L.; Wesselingh, S. L.; Mills, J.; Crowe, S. M. Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages J. Acquir. Immune Defic. Syndr. 2006, 42 (1) 19-28
12. Delaugerre, C.; Peytavin, G.; Dominguez, S.; Marcelin, A. G.; Duvivier, C.; Gourlain, K.; Amellal, B.; Legrand, M.; Raffi, F.; Costagliola, D.; Katlama, C.; Calvez, V. Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097) J. Med. Virol. 2005, 77 (3) 345-350
13. Dash, P. K.; Gendelman, H. E.; Roy, U.; Balkundi, S.; Alnouti, Y.; Mosley, R. L.; Gelbard, H.; McMillan, J.; Gorantla, S.; Poluektova, L. Long-acting nanoART elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice AIDS 2012, 26 (17) 2135-2144
14. Roy, U.; McMillan, J.; Alnouti, Y.; Gautum, N.; Smith, N.; Balkundi, S.; Dash, P.; Gorantla, S.; Martinez-Skinner, A.; Meza, J.; Kanmogne, G.; Swindells, S.; Cohen, S. M.; Mosley, R. L.; Poluektova, L.; Gendelman, H. E. Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte- reconstituted mice J. Infect. Dis. 2012, 206 (10) 1577-1588
15. Balkundi, S.; Nowacek, A. S.; Roy, U.; Martinez-Skinner, A.; McMillan, J.; Gendelman, H. E. Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs J. Vis. Exp. 2010, 2460
16. Dou, H.; Grotepas, C. B.; McMillan, J. M.; Destache, C. J.; Chaubal, M.; Werling, J.; Kipp, J.; Rabinow, B.; Gendelman, H. E. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS J. Immunol. 2009, 183 (1) 661-669
17. Kanmogne, G. D.; Singh, S.; Roy, U.; Liu, X.; McMillan, J.; Gorantla, S.; Balkundi, S.; Smith, N.; Alnouti, Y.; Gautam, N.; Zhou, Y.; Poluektova, L.; Kabanov, A.; Bronich, T.; Gendelman, H. E. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells Int J. Nanomed. 2012, 7, 2373-2388
18. Balkundi, S.; Nowacek, A. S.; Veerubhotla, R. S.; Chen, H.; Martinez-Skinner, A.; Roy, U.; Mosley, R. L.; Kanmogne, G.; Liu, X.; Kabanov, A. V.; Bronich, T.; McMillan, J.; Gendelman, H. E. Comparative manufacture and cell-based delivery of antiretroviral nanoformulations Int. J. Nanomed. 2011, 6, 3393-3404
19. Nowacek, A. S.; Balkundi, S.; McMillan, J.; Roy, U.; Martinez-Skinner, A.; Mosley, R. L.; Kanmogne, G.; Kabanov, A. V.; Bronich, T.; Gendelman, H. E. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages J. Controlled Release 2011, 150 (2) 204-211
20. Nowacek, A.; Gendelman, H. E. NanoART, neuroAIDS and CNS drug delivery Nanomedicine (London) 2009, 4 (5) 557-574
21. Kadiu, I.; Nowacek, A.; McMillan, J.; Gendelman, H. E. Macrophage endocytic trafficking of antiretroviral nanoparticles Nanomedicine (London) 2011, 6 (6) 975-994
22. Alberts, B. Molecular biology of the cell, 4 th ed.; Garland Science: New York, 2002.
23. Kraft-Terry, S. D.; Engebretsen, I. L.; Bastola, D. K.; Fox, H. S.; Ciborowski, P.; Gendelman, H. E. Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage J. Proteome Res. 2011, 10 (6) 2852-2862
24. Kraft-Terry, S. D.; Gendelman, H. E. Proteomic biosignatures for monocyte-macrophage differentiation Cell. Immunol. 2011, 271 (2) 239-255
25. Gendelman, H. E.; Orenstein, J. M.; Martin, M. A.; Ferrua, C.; Mitra, R.; Phipps, T.; Wahl, L. A.; Lane, H. C.; Fauci, A. S.; Burke, D. S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes J. Exp. Med. 1988, 167 (4) 1428-1441
26. Cox, J.; Neuhauser, N.; Michalski, A.; Scheltema, R. A.; Olsen, J. V.; Mann, M. Andromeda: a peptide search engine integrated into the MaxQuant environment J. Proteome Res. 2011, 10 (4) 1794-1805
27. Smyth, G. K.; Speed, T. Normalization of cDNA microarray data Methods 2003, 31 (4) 265-273
28. Bargagli, E.; Olivieri, C.; Cintorino, M.; Refini, R. M.; Bianchi, N.; Prasse, A.; Rottoli, P.; Calgranulin, B. (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis? Inflammation 2011, 34 (2) 85-91
29. Ghavami, S.; Kerkhoff, C.; Chazin, W. J.; Kadkhoda, K.; Xiao, W.; Zuse, A.; Hashemi, M.; Eshraghi, M.; Schulze-Osthoff, K.; Klonisch, T.; Los, M. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2 Biochim. Biophys. Acta 2008, 1783 (2) 297-311
30. Murray, H. W. Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates J. Exp. Med. 1981, 153 (6) 1690-1695
31. Nau, G. J.; Richmond, J. F.; Schlesinger, A.; Jennings, E. G.; Lander, E. S.; Young, R. A. Human macrophage activation programs induced by bacterial pathogens Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (3) 1503-1508
32. Hou, T.; Macmillan, H.; Chen, Z.; Keech, C. L.; Jin, X.; Sidney, J.; Strohman, M.; Yoon, T.; Mellins, E. D. An insertion mutant in DQA1 0501 restores susceptibility to HLA-DM: implications for disease associations J. Immunol. 2011, 187 (5) 2442-2452
33. Betts, M. R.; Gray, C. M.; Cox, J. H.; Ferrari, G. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development Expert Rev. Vaccines 2006, 5 (4) 505-516
34. Carmichael, A.; Jin, X.; Sissons, P.; Borysiewicz, L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease J. Exp. Med. 1993, 177 (2) 249-256
35. Clerici, M.; Giorgi, J. V.; Chou, C. C.; Gudeman, V. K.; Zack, J. A.; Gupta, P.; Ho, H. N.; Nishanian, P. G.; Berzofsky, J. A.; Shearer, G. M. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1 J. Infect. Dis. 1992, 165 (6) 1012-1019
36. Langlade-Demoyen, P.; Ngo-Giang-Huong, N.; Ferchal, F.; Oksenhendler, E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients J. Clin. Invest. 1994, 93 (3) 1293-1297
37. Rowland-Jones, S.; Sutton, J.; Ariyoshi, K.; Dong, T.; Gotch, F.; McAdam, S.; Whitby, D.; Sabally, S.; Gallimore, A.; Corrah, T. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women Nat. Med. 1995, 1 (1) 59-64
38. Alexaki, A.; Liu, Y.; Wigdahl, B. Cellular reservoirs of HIV-1 and their role in viral persistence Curr. HIV Res. 2008, 6 (5) 388-400
39. Bogdan, C. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example Cell. Microbiol. 2008, 10 (6) 1221-1234
40. Carter, C. A.; Ehrlich, L. S. Cell biology of HIV-1 infection of macrophages Annu. Rev. Microbiol. 2008, 62, 425-443
41. Deretic, V. Autophagy, an immunologic magic bullet: Mycobacterium tuberculosis phagosome maturation block and how to bypass it Future Microbiol. 2008, 3 (5) 517-524
42. Dussurget, O. New insights into determinants of Listeria monocytogenes virulence Int. Rev. Cell Mol. Biol. 2008, 270, 1-38
43. Ernst, J. D. Macrophage receptors for Mycobacterium tuberculosis Infect. Immun. 1998, 66 (4) 1277-1281
44. Hart, P. D.; Armstrong, J. A.; Brown, C. A.; Draper, P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria Infect. Immun. 1972, 5 (5) 803-807
45. Orenstein, J. M. Replication of HIV-1 in vivo and in vitro Ultrastruct. Pathol. 2007, 31 (2) 151-167
46. Schwanhausser, B.; Gossen, M.; Dittmar, G.; Selbach, M. Global analysis of cellular protein translation by pulsed SILAC Proteomics 2009, 9 (1) 205-209
47. Ricardo-Dukelow, M.; Kadiu, I.; Rozek, W.; Schlautman, J.; Persidsky, Y.; Ciborowski, P.; Kanmogne, G. D.; Gendelman, H. E. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia J. Neuroimmunol. 2007, 185 (1-2) 37-46
48. Tardieu, M.; Boutet, A. HIV-1 and the central nervous system Curr. Top. Microbiol. Immunol. 2002, 265, 183-195
49. Eugenin, E. A.; Osiecki, K.; Lopez, L.; Goldstein, H.; Calderon, T. M.; Berman, J. W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS J. Neurosci. 2006, 26 (4) 1098-1106
50. Persidsky, Y.; Ramirez, S. H.; Haorah, J.; Kanmogne, G. D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions J. Neuroimmune Pharmacol. 2006, 1 (3) 223-236
51. Mosser, D. M. The many faces of macrophage activation J. Leukocyte Biol. 2003, 73 (2) 209-212
52. Mosser, D. M.; Edwards, J. P. Exploring the full spectrum of macrophage activation Nat. Rev. Immunol. 2008, 8 (12) 958-969
53. Remick, D. G. Interleukin-8 Crit. Care Med. 2005, 33 (12 Suppl) S466-467
54. Stillie, R.; Farooq, S. M.; Gordon, J. R.; Stadnyk, A. W. The functional significance behind expressing two IL-8 receptor types on PMN J. Leukocyte Biol. 2009, 86 (3) 529-543
55. Deshmane, S. L.; Kremlev, S.; Amini, S.; Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview J. Interferon Cytokine Res. 2009, 29 (6) 313-326
56. Morohashi, H.; Miyawaki, T.; Nomura, H.; Kuno, K.; Murakami, S.; Matsushima, K.; Mukaida, N. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells J. Leukocyte Biol. 1995, 57 (1) 180-187
57. Holmes, W. E.; Lee, J.; Kuang, W. J.; Rice, G. C.; Wood, W. I. Structure and functional expression of a human interleukin-8 receptor Science 1991, 253 (5025) 1278-1280
58. Murphy, P. M.; Tiffany, H. L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor Science 1991, 253 (5025) 1280-1283